LKB1 was originally identified genetically as the tumour suppressor mutated in Peutz-Jeghers syndrome, an inherited susceptibility to cancer in humans [27], but it is also frequently mutated in sporadic (non-inherited) cancers, especially lung adenocarcinomas [28–31]. This evidence concerns the gene STK11 and cancer.